Immunocore

Public

Abingdon, EnglandBiotechhttps://www.immunocore.com/

Last Round

PIPE

Jul 18, 2022

Total Funding Raised

$1.08B

Company Overview

Immunocore is a biotechnology company that develops a novel class of TCR bispecific immunotherapies to treat cancer, infectious diseases, and autoimmune conditions.

Sector

Biotech

AI Layer

Non-AI

Keywords

T cell receptorTCRbispecific immunotherapyuveal melanomaImmTACtebentafuspcancer immunotherapybiotechoncologybiologicstargeted cancer therapyrare disease treatmentdrug developmentbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immunocore Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Immunocore Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
PIPE	Jul 18, 2022
Private Placement	Feb 5, 2021
IPO Announced	Feb 4, 2021
Debt	Jan 11, 2021
Series C	Jan 11, 2021
Series B	Mar 2, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Bahija Jallal

Chief Executive Officer

Executive Team

Travis Coy

Chief Financial Officer and Head of Corporate Development

Executive Team

Immunocore Investors

Notable investors and investment history

Investor	Rounds
Fidelity Management & Research Company	Series A
CCB International	Series B
Woodford Investment Management	Series A
The Bill & Melinda Gates Foundation Trust	Series B, Private Placement, Convertible Debt
JDRF	Series B
RTW Investments	Series A, Series B
Terra Magnum Capital Partners	Series B

View all Investors

Immunocore Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Immunocore Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersAbingdon, England

Employee Range603

Year Founded2008

Last FundingJul 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.